How concerned are we with the proliferation of dual-use technologies that could potentially be used for WMD development activities?

There appears to be significant overlap in the manufacturing capabilities of medical countermeasures between the DOD and the Department of Health and Human Services (DHHS).

What lessons has DOD learned from the Libya chemical weapons destruction mission?

the unfortunate recent and continued use of chemical weapons in Syria shows us that state sponsors of weapons of mass destruction not only seek these capabilities, but use these capabilities.

I am grateful to celebrate the strong relationship between Taiwan and the United States. With the 70th anniversary of the ending of World War II this year and the 36th anniversary of the Taiwan Relations Act on April 10, we can reflect how…

In a time of budget constraint, I believe DOD's limited resources are appropriately allocated according to the relative risks of chemical, biological, and nuclear threats.

Once the DOD's medical countermeasures advanced manufacturing facility is completed, will the Department be able to place orders for doses of countermeasures directly from the facility?

I support this legislation because I know it takes an important first step in stopping the spread of homegrown terrorism.

What are some of your unfunded requirements? Where are your largest gaps in funding?

How would you describe the level of information sharing and cooperation with the Intelligence Community to deal with the proliferation threat?

Given the emphasis placed on non-traditional agents by the Chem Bio Defense Program, how prepared are we to deal with new threats?

Is it really necessary that the DOD have independent manufacturing capabilities?

How effective are we at providing our troops with the most modern protective equipment for Chemical, Biological, Radiological and Nuclear (CBRN) threats?

What did you learn about the benefits of programmatic flexibility and anticipating of emerging threats from the Syria chemical weapon destruction mission?

Thank you, Chairman Price, for your extraordinary leadership. Mr. Chairman, I am grateful today to join with my House Armed Services Committee colleagues and speak in support of Chairman Price's defense alternative budget, Price 2. As the…

What is DOD doing to address Biothreats globally?

How do we prioritize which capability gaps we address, and in what order? Do we have adequate resources to fill those gaps?

What is currently being done in the way of consequence management planning and preparedness against Chemical, Biological, Radiological and Nuclear (CBRNE) attacks both abroad and within the U.S.?

What specific rebalancing does our Joint Force need to effectively deal with WMD, and what are our current shortfalls?

Can you discuss how current events in the Middle East and Northern Africa are impacting DTRA's operations and planning?

Thank you, Chairman Kline, for yielding. Mr. Speaker, I appreciate the chairman's leadership on this important issue, and I am grateful to be a cosponsor of this legislation. As a member of the House Education and the Workforce…

Congress built the sanction structure that brought Iran to the table, and if the President moves to dismantle it, we will have a say.

Any meaningful agreement must keep restrictions in place for decades, as over 360 Members of Congress, including every member of this committee, are demanding in a letter to the President this week.

Ladies and gentlemen, I call this briefing of the Emerging Threats and Capabilities Subcommittee of the House Armed Services Committee to order.

How is SOCOM working to resource Theater Special Operations Command intelligence requirements?